Literature DB >> 1321914

Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response.

S E Harding1, S M Jones, P O'Gara, F del Monte, G Vescovo, P A Poole-Wilson.   

Abstract

Single cardiac myocytes were isolated from the ventricles of failing and non-failing human hearts. The contraction amplitude, time-to-peak shortening and time to 50% and 90% relaxation were measured in cells stimulated at 0.2 Hz at 32 degrees C. The effects of increasing extracellular calcium and isoproterenol were investigated using cumulative concentration/response curves. Maximum contraction amplitude in high calcium or velocities of contraction or relaxation were not impaired in cells from failing hearts. Beta-adrenoceptor function in a single cell was assessed by the maximum contraction amplitude in the presence of isoproterenol relative to that with high calcium in the same cell (isoproterenol/calcium ratio). A decrease in the isoproterenol/calcium ratio correlated positively with an increase in the isoproterenol EC50 (concentration for half-maximal effect) for a cell (P less than 0.02, n = 39). The isoproterenol/calcium ratio in left ventricular myocytes decreased with increasing severity of disease, correlating with failure as defined by New York Heart Association class (P less than 0.001, n = 26 patients), left ventricular ejection fraction (P less than 0.001, n = 24), left ventricular end diastolic pressure (P less than 0.05, n = 21) and amount of diuretics prescribed (P less than 0.001, n = 26). In right ventricular myocytes, only increasing NYHA class correlated with decreasing isoproterenol/calcium ratios. There was a correlation of the isoproterenol/calcium ratio between right and left ventricular cells from patients with ischemic heart disease (P less than 0.05), n = 11). Beta-adrenoceptor subsensitivity occurred in mitral valve disease, ischemic heart disease, congenital abnormalities and congestive cardiomyopathy, but not in the right ventricle of patients with myocarditis. The isoproterenol/calcium ratio correlated negatively with the age of the patient (P less than 0.001, n = 26, left ventricle). Multiple regression indicated that the maximum contraction amplitudes in either high isoproterenol or high calcium declined significantly with age only, but that both age and severity of disease contributed to the decrease in isoproterenol/calcium ratio. Time-to-peak tension in isoproterenol, as well as relaxation times in high calcium also decreased with the age of the patient. Analysis of variance showed that between-patient variation was significantly greater than between-cell for most of the parameters measured. Beta-adrenoceptor desensitisation may be detected in individual myocytes from failing hearts, and this relates more to the severity of disease and the age of the patient rather than the etiology of heart failure. A decline in absolute contractility of muscle cells with age was detected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321914     DOI: 10.1016/0022-2828(92)91843-t

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  22 in total

1.  Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts.

Authors:  S E Harding; L A Brown; F del Monte; C H Davies; P O'Gara; G Vescovo; D G Wynne; P A Poole-Wilson
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

2.  Modeling the effects of β1-adrenergic receptor blockers and polymorphisms on cardiac myocyte Ca2+ handling.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Mol Pharmacol       Date:  2014-05-27       Impact factor: 4.436

3.  Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.

Authors:  S E Harding; U Schmidt; T Matsui; Z B Kang; G W Dec; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

4.  Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.

Authors:  Luca Troncone; Marco Luciani; Matthew Coggins; Elissa H Wilker; Cheng-Ying Ho; Kari Elise Codispoti; Matthew P Frosch; Rakez Kayed; Federica Del Monte
Journal:  J Am Coll Cardiol       Date:  2016-12-06       Impact factor: 24.094

5.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.

Authors:  G Vescovo; F Serafini; L Facchin; P Tenderini; U Carraro; L Dalla Libera; C Catani; G B Ambrosio
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

Review 6.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

7.  Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery.

Authors:  Zsuzsanna Callaerts-Vegh; Kenda L J Evans; Gregory L Shipley; Peter J A Davies; Donald L Cuba; Hunaid A Gurji; Heather Giles; Richard A Bond
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.

Authors:  D G Wynne; P A Poole-Wilson; S E Harding
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 9.  Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels.

Authors:  Edward G Lakatta; Mingyi Wang; Samer S Najjar
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

10.  Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.

Authors:  Nina S Ghais; Yanmin Zhang; Andrew A Grace; Christopher L-H Huang
Journal:  Exp Physiol       Date:  2008-10-31       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.